Skip to main content
. 2023 Feb 8;29(2):99–110. doi: 10.1089/jicm.2022.0699

FIG. 3.

FIG. 3.

(A) Perceived itching intensity on a VAS through 26 weeks in HTP, IFDP, control, and EP. Values are means and standard deviations. (B) Disease severity by SCORAD through 26 weeks in HTP, IFDP, control, and EP. Values are means and standard deviations. (C) Perceived total severity of all AD symptoms on a VAS through 26 weeks in HTP, IFDP, control, and EP. Values are means and standard deviations. (D) Disease-specific quality of life by the DLQI through 26 weeks in HTP, IFDP, control, and EP. Values are means and standard deviations. (E) Perceived skin condition on a VAS through 26 weeks in HTP, IFDP, control, and EP. Values are means and standard deviations. AD, atopic dermatitis; DLQI, Dermatology Life Quality Index; EP, exercise group program; HTP, hypnotherapy group program; IFDP, intermittent fasting with diet adjustment group program; SCORAD, SCORing Atopic Dermatitis; VAS, visual analogue scale.